Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Horwitz

Showing results (271-280 of 510) with videos related to

Pageof 51
Sort By:
The Journal of Biological Chemistry|November 5, 1991
Domain mapping of the photoaffinity drug-binding sites in P-glycoprotein encoded by mouse mdr1bL M Greenberger, C J Lisanti, J T Silva, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
Vinca alkaloidsB A Chabner, S B Horwitz, N J Clendennin, et al.
Recent Progress in Hormone Research|January 1, 1985
Progestin action and progesterone receptor structure in human breast cancer: a reviewK B Horwitz, L L Wei, S M Sedlacek, et al.
Journal of Steroid Biochemistry|November 1, 1986
Progesterone metabolism in T47Dco human breast cancer cells--I. 5 alpha-pregnan-3 beta,6 alpha-diol-20-one is the secreted productP V Fennessey, A W Pike, C Gonzalez-Aller, et al.
Journal of Receptor Research|January 1, 1985
The effect of platelet protein and DNA on the measurement of human lymphocyte beta adrenergic receptor numberW R Hiatt, V L Travis, K B Horwitz, et al.
The Journal of Biological Chemistry|April 7, 2000
The mouse mammary tumor virus promoter adopts distinct chromatin structures in human breast cancer cells with and without glucocorticoid receptorH K Kinyamu, C J Fryer, K B Horwitz, et al.
Breast Cancer Research and Treatment|January 5, 2002
Desferri-exochelin induces death by apoptosis in human breast cancer cells but does not kill normal breast cellsP M Pahl, M A Horwitz, K B Horwitz, et al.
Science (New York, N.Y.)|May 6, 1977
Human breast cancer: biologically active estrogen receptor in the absence of estrogen?D T Zava, G C Chamness, K B Horwitz, et al.
Cancer Research|February 1, 1992
Heterogeneity of progesterone receptor content and remodeling by tamoxifen characterize subpopulations of cultured human breast cancer cells: analysis by quantitative dual parameter flow cytometryM L Graham, J A Smith, P B Jewett, et al.
Science (New York, N.Y.)|October 8, 1971
Chemosterilant action of anthramycin: a proposed mechanismS B Horwitz, S C Chang, A P Grollman, et al.
Pageof 51

Showing results (271-280 of 510) with videos related to

Sort By:
Pageof 51
The Journal of Biological Chemistry|November 5, 1991
Domain mapping of the photoaffinity drug-binding sites in P-glycoprotein encoded by mouse mdr1bL M Greenberger, C J Lisanti, J T Silva, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
Vinca alkaloidsB A Chabner, S B Horwitz, N J Clendennin, et al.
Recent Progress in Hormone Research|January 1, 1985
Progestin action and progesterone receptor structure in human breast cancer: a reviewK B Horwitz, L L Wei, S M Sedlacek, et al.
Journal of Steroid Biochemistry|November 1, 1986
Progesterone metabolism in T47Dco human breast cancer cells--I. 5 alpha-pregnan-3 beta,6 alpha-diol-20-one is the secreted productP V Fennessey, A W Pike, C Gonzalez-Aller, et al.
Journal of Receptor Research|January 1, 1985
The effect of platelet protein and DNA on the measurement of human lymphocyte beta adrenergic receptor numberW R Hiatt, V L Travis, K B Horwitz, et al.
The Journal of Biological Chemistry|April 7, 2000
The mouse mammary tumor virus promoter adopts distinct chromatin structures in human breast cancer cells with and without glucocorticoid receptorH K Kinyamu, C J Fryer, K B Horwitz, et al.
Breast Cancer Research and Treatment|January 5, 2002
Desferri-exochelin induces death by apoptosis in human breast cancer cells but does not kill normal breast cellsP M Pahl, M A Horwitz, K B Horwitz, et al.
Science (New York, N.Y.)|May 6, 1977
Human breast cancer: biologically active estrogen receptor in the absence of estrogen?D T Zava, G C Chamness, K B Horwitz, et al.
Cancer Research|February 1, 1992
Heterogeneity of progesterone receptor content and remodeling by tamoxifen characterize subpopulations of cultured human breast cancer cells: analysis by quantitative dual parameter flow cytometryM L Graham, J A Smith, P B Jewett, et al.
Science (New York, N.Y.)|October 8, 1971
Chemosterilant action of anthramycin: a proposed mechanismS B Horwitz, S C Chang, A P Grollman, et al.
Pageof 51